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Mycoplasma mycoides subsp. mycoides SC, the aetiological agent of contagious bovine pleuropneumonia (CBPP), is considered the
most pathogenic of the Mycoplasma species. Its virulence is probably the result of a coordinated action of various components of an
antigenically and functionally dynamic surface architecture. The diﬀerent virulence attributes allow the pathogen to evade the host’s
immune defence, adhere tightly to the host cell surface, persist and disseminate in the host causing mycoplasmaemia, eﬃciently import
energetically valuable nutrients present in the environment, and release and simultaneously translocate toxic metabolic pathway products
to the host cell where they cause cytotoxic eﬀects that are known to induce inﬂammatory processes and disease. This strategy enables the
mycoplasma to exploit the minimal genetic information in its small genome, not only to fulﬁl the basic functions for its replication but
also to damage host cells in intimate proximity thereby acquiring the necessary bio-molecules, such as amino acids and nucleic acid pre-
cursors, for its own biosynthesis and survival.
 2006 Elsevier Ltd.
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Mycoplasma mycoides subsp. mycoides small colony
type (SC) is the aetiological agent of contagious bovine
pleuropneumonia (CBPP), a severe infectious disease of
cattle (Food and Agriculture Organization, 2003). Myco-
plasma species are the smallest self-replicating organisms
currently found on our planet. Their genomes range from
580 kb for Mycoplasma genitalium (Fraser et al., 1995) to
1358 kb for Mycoplasma penetrans (Sasaki et al., 2002),
while that of M. mycoides subsp. mycoides SC has a size
of 1211 kb (Westberg et al., 2004). This minimal genome
has led the Mycoplasma species to radically economise1090-0233  2006 Elsevier Ltd.
doi:10.1016/j.tvjl.2006.10.016
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Open access under CC BY license.genetic resources and biosynthetic capacities, and adapt
to an obligate parasitic lifestyle (Razin, 1997).
The minimal cellular genome of mycoplasmas also
serves as a blueprint for the design of synthetic live organ-
isms (Check, 2002). In contrast to other pathogenic bacte-
ria, where virulence is determined mainly by toxins,
cytolysins and invasins, no such typical primary virulence
genes have been found on the genomes of the ten Myco-
plasmas species that have been sequenced completely (Fra-
ser et al., 1995; Himmelreich et al., 1996; Glass et al., 2000;
Chambaud et al., 2001; Sasaki et al., 2002; Papazisi et al.,
2003; Jaﬀe et al., 2004; Minion et al., 2004; Vasconcelos
et al., 2005). Mycoplasmas seem rather to use intrinsic met-
abolic and catabolic functions to cause disease in the
aﬀected host and to ensure the microbe’s survival (Abu-
Groun et al., 1994; Baseman and Tully, 1997; Razin,
1997; Vilei and Frey, 2001; Pilo et al., 2005). Analysis of
data from a severe mycoplasmal pathogen, such as
M. mycoides subsp. mycoides SC, is expected not only to
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CBPP, but may also be useful in the better understanding
of other pathogenic Mycoplasma species.
CBPP is the only animal disease belonging to the A list
of most severe infectious animal diseases (as deﬁned by the
World Organisation for Animal Health – Oﬃce Interna-
tional des Epizooties, OIE) caused by a bacterium as a
transmissible agent. CBPP has the potential for very seri-
ous and rapid spread across national borders. It is cur-
rently responsible for major losses in livestock production
in Africa and, therefore, has serious socio-economic conse-
quences and is of major importance in the international
trade of animals and animal products. In most other parts
of the world, CBPP was eradicated using drastic policies of
stamping out cattle in infected areas, control of cattle
movement, and quarantine (Turner, 1954, 1959). The re-
emerging outbreaks of CBPP in some European countries
at the end of the last century demonstrated the constant
threat of the disease to industrialized countries and
required the re-introduction of expensive eradication mea-
sures (Egwu et al., 1996).
The basic requirements to control CBPP are highly eﬃ-
cient diagnostic tests that detect M. mycoides subsp. myco-
ides SC not only in symptomatic animals but also in
asymptomatic carriers, together with vaccine strategies that
are able to reduce the infectious pressure in infected areas
by preventing the pathogen from achieving host infection,
colonization, and multiplication (Thiaucourt et al., 1998;
Thiaucourt, 2002). In this context, it is worth noting that
the live vaccines currently used to control CBPP in diﬀerent
regions of Africa were derived from strain T1 of M. myco-
ides subsp. mycoides SC, which was developed in Tanzania
in the 1950s. The eﬃcacy of T1 vaccine strains have been
evaluated on several occasions and they have shown
advantages but also drawbacks (Hubschle et al., 2002).
For instance, cattle that were infected experimentally with
strain T1/44 (or that were in contact with T1/44-infected
animals) developed severe lung lesions characteristic for
CBPP (Mbulu et al., 2004). Molecular analyses conﬁrmed
the identity of re-isolated T1/44, therefore the observed
pathologies were attributed to this particular vaccine
strain. Furthermore, inactivated whole cell vaccines
appeared to exacerbate the eﬀects of CBPP in adult cattle;
as a result there have been few challenges with inactivated
vaccines (Nicholas et al., 2004).
To cause disease or to be virulent, M. mycoides subsp.
mycoides SC possesses particular mechanisms to adhere
to the speciﬁc host tissue, to evade the host’s immune
defence, to enable persistence and dissemination in the
infected animal, and to cause inﬂammation and disease
signs through cytotoxicity. The loss of any of these mech-
anisms can lead to attenuation or loss of virulence. Hence,
a detailed knowledge of the molecular mechanisms of path-
ogenicity of M. mycoides subsp. mycoides SC is both a pre-
requisite to develop accurate diagnostic methods that allow
pathogen detection and diﬀerentiate it from closely related
bacterial species residing within the host, and to design safeand eﬃcient vaccines. While the total virulence ofM. myco-
ides subsp. mycoides SC can only be determined by expen-
sive experimental infections of cattle, which are diﬃcult to
justify ethically, the various individual molecular mecha-
nisms that contribute to virulence, such as adherence, anti-
genic variation, impact of capsular polysaccharides to
allow persistence and dissemination in the host, or cyto-
toxic activity, can be studied by means of diverse in vitro
immunoassays, cellular studies, or experimental mouse
infection assays.
The recently established sequence of the complete gen-
ome of M. mycoides subsp. mycoides SC did not reveal
any primary virulence factors such as toxins or invasins
(Westberg et al., 2004). Therefore, the molecular mecha-
nisms of pathogenicity of M. mycoides subsp. mycoides
SC, as well as of most other Mycoplasma species, are ‘‘hid-
den’’ and require a consideration of the particularities of
metabolic pathways, surface antigens, and their regulation.
The present review will give a short overview of the molec-
ular mechanisms of pathogenicity that have been unrav-
elled to date and discuss their impact on the virulence of
M. mycoides subsp. mycoides SC. In spite of the host spec-
iﬁcity of M. mycoides subsp. mycoides SC, many basic
molecular mechanisms of virulence are also expected to
be found in other Mycoplasma species. DNA sequence
analysis has revealed that the genomes of mycoplasmas
consist of a minimal set of genes encoding the essential
functions of life, which are conserved in most species and
subspecies.
2. Immunopathogenicity
The principal pathological consequence of M. mycoides
subsp. mycoides SC infections is a massive inﬂammatory
reaction mainly restricted to the lungs of the aﬀected cattle,
leading to death by respiratory distress caused by lung con-
solidation in up to 30% of cases (Provost et al., 1987; Food
and Agriculture Organization, 2003). In most infected cat-
tle, however, CBPP is manifested in a chronic form, which
allows the host to recover from disease but to remain a
potential carrier of the pathogen and so a threatening res-
ervoir of M. mycoides subsp. mycoides SC (Provost et al.,
1987; Food and Agriculture Organization, 2003).
Dedieu and collaborators (2005a) recently studied the
diﬀerence between the acute and chronic progression of
CBPP in cattle at the molecular level. The authors per-
formed a kinetic analysis of the response of cattle to an
infection by M. mycoides subsp. mycoides SC and showed
that in animals that recovered from disease, the CD4
Th1-like T-cell response to M. mycoides subsp. mycoides
SC was maintained over a long period (until slaughter of
the animals in the experiment). In contrast, in animals that
developed an acute disease, progression of the symptomatic
CBPP was associated with a decreased ability of the periph-
eral blood mononuclear cells to produce interferon (Dedieu
et al., 2005a). These data indicated that the susceptibility of
cattle to infection by M. mycoides subsp. mycoides SC is
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that allows dissemination of the pathogen and progression
of immunopathologies.
In an in vitro study on the apoptotic eﬀect of M. myco-
ides subsp. mycoides SC on bovine peripheral blood mono-
nuclear cells, Dedieu et al. (2005b) demonstrated that
viableM. mycoides subsp. mycoides SC could induce strong
morphological changes in the mononuclear cells, as evi-
denced by a reduction of cell size and increase of cell gran-
ularity, while heat-killed M. mycoides subsp. mycoides SC
had no eﬀect. This cytopathic eﬀect was shown to be the
cause of apoptosis of the mononuclear cells triggered by
live M. mycoides subsp. mycoides SC or by a substance
released by mycoplasmas. However, the triggering eﬀect
measured by mycoplasma free culture supernatants was
rather low (Dedieu et al., 2005b), suggesting that the trig-
gering agent has a short half-life or acts only over very
short distances.
Several other reports suggest that potentially secreted
substances of M. mycoides subsp. mycoides SC may be
the cause of the immunopathological eﬀects of CBPP.
However, the results of genomic DNA sequence analysis
of M. mycoides subsp. mycoides SC (Westberg et al.,
2004), as well as genome sequences of other Mycoplasma
species, did not reveal any particular candidate molecules
that could be directly identiﬁed as molecular triggers for
apoptosis or cell necrosis.Fig. 1. Schematic representation of the various virulence pathways ofM. mycoi
cells in light blue. The upper pathway, which is currently the best characteriz
membrane-located ATP-binding cassette (ABC) transporter system, which inc
(G3P). The bypass pathway that allows diﬀusion of glycerol via the glycerol fa
kinase (GlpK) has not been evidenced directly, but the corresponding genes, glp
their functionality was supported by strains lacking functional gtsABC genes, w
glycerophosphate oxidase (GlpO) represents the central enzyme in this virulence
into the host cell. The adhesins that seem necessary for the close contact are st
role in evading the host’s immune defence. Capsular polysaccharide has been
induce cytokine production. Lipoprotein LppQ is highly antigenic and also
superantigen-like properties. Catabolism of glucosides by the phosphotransfer
virulence of many pathogens.3. Secreted polycarbohydrates and capsular polysaccharide
Molecules located on the outer surface or in the plasma
membrane of Mycoplasma species, such as lipoproteins,
capsular polysaccharides and bioﬁlms composed mainly
of ﬁbrillar polycarbohydrates surrounding cells, are gener-
ally assumed to protect the pathogen from the bactericidal
activity of complement and other host defence functions,
and to trigger the inﬂammatory process in the infected host
(Fig. 1). Bioﬁlms lead bacteria to adhere among themselves
and to form micro-colonies on mucosal surfaces and inert
materials that are mostly resistant to bactericidal activity
of the host and to antibiotics. However, M. mycoides
subsp. mycoides SC does not form bioﬁlms as shown in a
recently published study, where 25 strains from diﬀerent
origins and with variable degrees of virulence were tested
for bioﬁlm production (McAuliﬀe et al., 2006).
The capsular polysaccharide galactan, composed of 6-O-
b-D-galactofuranosyl-D-galactose (Plackett and Buttery,
1964), was shown to increase the virulence of the strongly
attenuated M. mycoides subsp. mycoides SC vaccine strain
KH3J when added to the inoculum prior to experimental
infections of cattle (Hudson et al., 1967). Moreover, But-
tery et al. (1976) showed that intravenous injection of
galactan from M. mycoides subsp. mycoides SC to calves
produced transient apnoea, increased pulmonary arterial
pressure and pulmonary oedema, indicating that capsulardes subsp. mycoides SC. The mycoplasma is represented in yellow, the host
ed, is based on glycerol import and metabolism. GtsABC represents the
orporates and phosphorylates imported glycerol to glycerol-3-phosphate
cilitator factor (GlpF) and the subsequent phosphorylation by the glycerol
F and glpK, have been found by cloning and DNA sequence analysis, and
hich can import and phosphorylate glycerol. The membrane-located L-a-
pathway and is able to translocate H2O2 or reactive oxygen species (ROS)
ill hypothetical. The variable surface antigen (Vmm) is supposed to play a
proposed to be produced by most Mycoplasma species and is expected to
seems to be involved in the induction of inﬂammatory processes by
ase system (PTS) and 6-phospho-b-glucosidase (Bgl) is known to repress
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and seems to lead to the contraction of blood vessels, which
may initiate thrombosis. The impact of capsular polysac-
charide on virulence was also shown by growth inhibition
tests, which primarily measure serum resistance, and by a
mouse infection model, which mainly measures the capac-
ity of the Mycoplasma strain to cause bacteraemia.
March et al. (1999) showed that a strain of M. mycoides
subsp. mycoides SC that produces low amounts of capsular
polysaccharide was much more sensitive to growth inhibit-
ing antisera than strains that produced larger amounts of
polysaccharide. Furthermore, the same strains that pro-
duced large amounts of capsular polysaccharide also gener-
ated a signiﬁcantly longer duration of bacteraemia in a
mouse infection assay than the strain with little capsular
polysaccharide (March and Brodlie, 2000). Hence, capsular
polysaccharide seems to play a role in the capacity of per-
sistence and dissemination of M. mycoides subsp. mycoides
SC in the infected host (Fig. 1). This process is independent
of the strain’s capacity to release H2O2 upon glycerol
uptake and metabolism, a mechanism that aﬀects the cyto-
toxicity of M. mycoides subsp. mycoides SC (Vilei and
Frey, 2001; Pilo et al., 2005). For this reason, the virulence
(as measured using the mouse infection assay) and the abil-
ity of the diﬀerent strains of M. mycoides subsp. mycoides
SC to metabolize glycerol were assumed to be unconnected,
as reported previously (March and Brodlie, 2000).
4. Surface proteins
Lipoproteins are expected to play a role as triggers in
mechanisms of pathogenicity, since they are known to have
a central role in interactions between mycoplasmas and
eukaryotic cells, particularly with respect to adhesion. Fur-
thermore, lipoproteins have been reported to stimulate the
release of pro-inﬂammatory cytokines (Mu¨hlradt and
Frisch, 1994; Herbelin et al., 1994; Brenner et al., 1997;
Marie et al., 1999; Calcutt et al., 1999). Since lipoproteins
are usually strongly antigenic proteins, they are also con-
sidered to be valuable targets for speciﬁc and sensitive sero-
diagnosis. Currently, a few lipoproteins from M. mycoides
subsp. mycoides SC have been characterized in detail. Most
of them are major antigens and are readily detected in the
serum of infected cattle on immunoblots.
LppA is strongly conserved among mycoplasmas of the
‘‘M. mycoides cluster’’ and it is expressed by highly virulent
Mycoplasma species as well as by non-pathogenic or low-
pathogenic species (Monnerat et al., 1999a; Monnerat
et al., 1999b). The role of LppA in Th1 and Th2 immunity
is currently under investigation. LppB is found only in
strains belonging to the African/Australian cluster, but is
not found in strains isolated from the re-emerging Euro-
pean outbreaks in 1980–1999. LppB is, however, also pres-
ent in other mycoplasmas of the ‘‘M. mycoides cluster’’, in
particular, in the bovine pathogen Mycoplasma sp. bovine
group 7 (Vilei et al., 2000). Another lipoprotein, LppC,
which is expressed by all M. mycoides subsp. mycoidesSC strains, is also found in other, less pathogenic Myco-
plasma species (Pilo et al., 2003). Hence, the role of these
lipoproteins in virulence is still unclear. LppQ is a lipopro-
tein speciﬁc to M. mycoides subsp. mycoides SC. It has a
particularly strong antigenic N-terminal domain located
on the outer surface of the membrane, while its C-terminal
domain is involved in membrane anchoring (Abdo et al.,
2000).
The high speciﬁcity and strong antigenicity of LppQ
have been exploited for the development of a robust indi-
rect ELISA test for serological diagnosis and for epidemi-
ological investigations of CBPP (Bruderer et al., 2002).
Structural analysis of LppQ showed strong similarities to
proteins with super-antigenic character (Abdo et al.,
2000). A recent study has shown that cattle immunized
with puriﬁed recombinant LppQ, using diﬀerent adjuvant
methods, were signiﬁcantly more susceptible to challenge
with M. mycoides subsp. mycoides SC than cattle that were
not vaccinated with LppQ (Nicholas et al., 2004). Hence,
LppQ is assumed to play an adverse reaction in vaccina-
tion, similar to the peptidoglycan-associated lipoprotein
PalA of Actinobacillus pleuropneumoniae, which was shown
to completely inhibit the beneﬁcial eﬀects of eﬃcient sub-
unit vaccines when animals were vaccinated simultaneously
with PalA (van den Bosch and Frey, 2003). LppQ may
therefore contribute to the immunopathologies induced
by M. mycoides subsp. mycoides SC (Fig. 1).
5. Adhesion factors
Adhesins play an important role in the early steps of
pathogenesis of most microorganisms. Since mycoplasmas
do not seem to secrete toxins that could act over long dis-
tances, adhesion is particularly important in mycoplasmal
virulence. Adhesion plays a central role in the intimate
interactions of pathogenic mycoplasmas with mammalian
cells for long periods and is assumed to trigger a cascade
of signals, which are transduced to the host cell and induce
inﬂammation (Razin et al., 1998). Adhesins also seem to be
responsible for host speciﬁcity and tissue tropism.
Although several adhesins have been identiﬁed in various
Mycoplasma species (Sachse et al., 1996; Noormohammadi
et al., 1997; Razin et al., 1998; Kitzerow et al., 1999;
Sachse et al., 2000; Minion et al., 2000; Fleury et al.,
2002; Belloy et al., 2003), speciﬁc adhesins have not yet
been detected in M. mycoides subsp. mycoides SC, but
can be postulated to occur from the above considerations.
6. Variable surface proteins
Phase variation is a common mechanism among Myco-
plasma species and is thought to be involved in microbial
survival, leading to the emergence of varied intra-clonal
populations that adapt quickly to new environments (Dyb-
vig and Voelker, 1996; Henderson et al., 1999). Some
Mycoplasma species possess an abundance of phase-vari-
able proteins, especially surface-exposed lipoproteins (Citti
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ison et al., 2005).
A variable surface protein, designated Vmm, has been
discovered in M. mycoides subsp. mycoides SC (Persson
et al., 2002). Vmm is a 16-kDa protein, speciﬁc to this
Mycoplasma species. It is expressed by nearly all strains
analyzed, where it has shown a reversible ON–OFF phase
variation at a high frequency per cell generation. This var-
iation is regulated at the transcriptional level by dinucleo-
tide insertions or deletions in a repetitive region of the
promoter (Persson et al., 2002). Genes resembling the
vmm gene were also found in other species of mycoplasma,
but analogous Vmm-like proteins in these species could not
be detected with a speciﬁc monoclonal antibody directed to
Vmm of M. mycoides subsp. mycoides SC. The function of
Vmm is currently unknown, but repeating elements in var-
iable membrane proteins of mycoplasmas have been sug-
gested to increase the pathogen’s ability to adhere to host
cells and to evade the host immune response (Peterson
et al., 1995; Sachse et al., 2000) (Fig. 1).
7. Toxic metabolic pathway products
Oxygen uptake and H2O2 production were identiﬁed as
particular characteristics in fermentative Mycoplasma spe-
cies and were expected to inﬂuence the virulence of patho-
genic mycoplasmas (Cole et al., 1968; Brennan and
Feinstein, 1969; Wadher et al., 1990; Miles et al., 1991).
It was later discovered that M. mycoides subsp. mycoides
SC strains isolated from the re-emerging European out-
breaks of CBPP in 1980–1999 produced much less H2O2
when grown in the presence of glycerol than strains isolated
in the African and Australian continents and it was sug-
gested that a glycerophosphate oxidase could represent a
signiﬁcant virulence factor of M. mycoides subsp. mycoides
SC (Wadher et al., 1990; Houshaymi et al., 1997; Rice
et al., 2001).
Recently, the role of glycerol metabolism in the viru-
lence of M. mycoides subsp. mycoides SC was also consid-
ered in our laboratory, based on the observation that
African strains contain an eﬃcient active glycerol import
system, GtsABC, speciﬁed by an ABC transporter protein,
while the European strains, which are considered less viru-
lent (Abdo et al., 1998) and cause a disease that appears to
be largely chronic showing few clinical signs and low mor-
tality (Nicholas et al., 1996), are devoid of this transporter
protein (Vilei and Frey, 2001). Glycerol is metabolized
after uptake and phosphorylation to dihydroxyacetone
phosphate (DHAP) by an oxidative process leading to
the release of the highly toxic compound H2O2. Blocking
the glycerol uptake proteins GtsABC by speciﬁc antibodies
resulted in a signiﬁcant reduction of H2O2 production
(Vilei and Frey, 2001). Furthermore, it was shown that
European strains that lack the GtsABC transporter pro-
duce signiﬁcantly lower amounts of H2O2.
The L-a-glycerophosphate oxidase (GlpO), which cata-
lyzes the oxidation of glycerol-3-phosphate (G3P) accom-panied by the release of a molecule of H2O2, was
identiﬁed as the membrane protein that plays a central role
in cytotoxicity of M. mycoides subsp. mycoides SC strains
towards embryonic calf nasal epithelial (ECaNEp) cells
(Pilo et al., 2005). In the presence of physiological concen-
trations of glycerol, relatively large amounts of H2O2 were
released into the culture medium. When ECaNEp cells
were exposed to African M. mycoides subsp. mycoides SC
ﬁeld strains in the presence of physiological concentrations
of glycerol, H2O2 was rapidly detected in their cytosol and,
subsequently, cell death occurred. Only a weak cytotoxic
eﬀect was observed when ECaNEp cells were infected with
European strains. Culture supernatants from M. mycoides
subsp. mycoides SC grown in the presence of glycerol, and
thus containing up to 150 lM H2O2, or buﬀers or axenic
culture media supplemented with 150 lM H2O2 had no
cytotoxic eﬀect on ECaNEp cells. In these cases, H2O2 or
the accompanying reactive oxygen species (ROS) could
not be detected in the cytosol of the eukaryotic cells (Pilo
et al., 2005). Hence, close contact between mycoplasmas
and host cells was necessary in order to successfully trans-
locate the toxic compounds from the glycerol metabolism
into the host cells. In this context, it is worth noting that
most Mycoplasma species, including M. mycoides subsp.
mycoides SC, remain tightly attached to the surface of epi-
thelial cells but do not penetrate them (for review see Razin
et al., 1998). A possible mechanism of adhesion, particu-
larly in calf epithelial cells, could be the partial fusion of
the surface exposed epitopes of M. mycoides subsp. myco-
ides SC with the host cell wall (Pilo et al., 2005).
A proposed model for triggering cellular damage to
eukaryotic cells is that glycerol present in the interstitial
ﬂuid is incorporated actively via the highly active ABC
glycerol transporter GtsABC and is subsequently phos-
phorylated into G3P. This, in turn, is oxidized by GlpO
into DHAP, which enters in the glycolysis cycle of the
mycoplasma, and H2O2 is released. Facilitated by the inti-
mate contact of the mycoplasma with the host cell mem-
brane, H2O2 or ROS enters the host cell. Inside the host
cells, these toxic compounds act as powerful mediators of
cell injury and inducers of inﬂammatory processes
(Fig. 1). They are expected to damage the host either by
directly impairing tissue cells or by inducing host gene
expression, e.g. of pro-inﬂammatory genes via activation
of the nuclear factor kappa B (NF-jB) (Baeuerle and Hen-
kel, 1994), or via the Fenton reaction (Crichton et al.,
2002).
Interestingly, mycoplasmas have previously been shown
to induce a respiratory burst in phagocyte cells (Koppel
et al., 1984), suggesting that host-generated ROS might
further contribute to tissue damage. Furthermore, it was
shown that M. mycoides subsp. mycoides SC strains are
also able to induce the tumor necrosis factor alpha
(TNF-a) in bovine alveolar macrophages (Jungi et al.,
1996). TNF-a also acts as an inﬂammatory mediator and,
in association with NF-jB, can act as primary signals
inducing apoptosis in host cells. The demonstration of
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pathway triggered by M. mycoides subsp. mycoides SC in
host cells must be investigated.
8. Catabolite repression of bacterial virulence
A non-synonymous single nucleotide polymorphism
(SNP) in the bgl gene encoding the 6-phospho-b-glucosidase
(Bgl) has recently been detected. It diﬀerentiates African
ﬁeld strains from European ﬁeld strains from the 1980–
1999 outbreaks, as well as currently used vaccine strains
of M. mycoides subsp. mycoides SC (Vilei and Frey, 2004).
Bgl is an intracellular enzyme associated with the phospho-
enolpyruvate-dependent sugar:phosphotransferase system
(PEP–PTS), a multicomponent system involved in the
simultaneous translocation and phosphorylation of sugars
by bacteria from both Gram-positive and Gram-negative
genera. Sugars in general and sugar catabolites are known
to mediate repression of bacterial virulence gene expression;
in particular, catabolism of b-glucosides is involved in the
regulation of the virulence of bacterial pathogens, such as
Listeria monocytogenes (Brehm et al., 1999) and Erwinia
amylovora (Kerppola et al., 1987). Hence, it will be worth-
while in the future to analyze the role of the bgl gene in
attenuated strains of M. mycoides subsp. mycoides SC,
and to investigate whether the resulting enzyme shows a
regulated activity that would be able to catabolically modu-
late the mycoplasmal virulence characteristics.
9. Concluding remarks
The pathogenicity of M. mycoides subsp. mycoides SC
seems to be multifunctional, as would be expected from
knowledge of the molecular mechanisms of pathogenicity
from other bacterial species. However, in contrast to the
latter, whose virulence is determined by special virulence
factors such as toxins and invasins, the virulence factors
of Mycoplasma species seem to be determined by intrinsic
metabolic or catabolic pathway functions or by proper
constituents of the mycoplasmal outer surface. InM. myco-
ides subsp. mycoides SC, a few virulence determinants have
been unravelled in recent years including capsular polysac-
charide, which seems to be involved in serum-resistance to
give the organism the capacity to persist and disseminate in
the host. In addition, there are unknown but necessary
adhesion factors, immunomodulating factors, and toxic
metabolic pathway products, which exert cytotoxic eﬀects
and can induce inﬂammatory reactions in the host. All
these virulence mechanisms are measured by various
in vitro or biological assays.
The loss of any of these virulence mechanisms can lead
to attenuation or, potentially, to avirulence, even when all
the other virulence attributes are still fully active. This is
well known for many other bacterial pathogens. For exam-
ple, in Bacillus anthracis, the loss of the capsule biosynthe-
sis genes on plasmid pXO2 leads to an avirulent strain. The
latter is currently used as a live vaccine, in spite of the pres-ence of the oedema factor and the lethal toxin (Brossier
and Mock, 2001). It is therefore not surprising that M.
mycoides subsp. mycoides SC strains, such as KH3J, that
produce low amounts of capsular polysaccharide and have
lost most of their potential to cause bacteraemia in mice
but still produce large amounts of H2O2 by their capacity
to import and metabolize glycerol, have a strongly attenu-
ated virulence (Lloyd et al., 1971; Dyson and Smith, 1976;
March et al., 1999; March and Brodlie, 2000; Rice et al.,
2001).
The various approaches and methods to study virulence
ofM. mycoides subsp. mycoides SC target individual mech-
anisms. To assess the overall virulence of M. mycoides
subsp. mycoides SC, all of these diﬀerent mechanisms of
pathogenicity would have to be considered. Currently, a
major handicap in the study of the basic principles of the
diﬀerent virulence mechanisms of M. mycoides subsp.
mycoides SC is the lack of a genetic basis for most of them.
In order for research on the molecular mechanisms of path-
ogenicity of M. mycoides subsp. mycoides SC to progress,
eﬃcient tools for targeted mutagenesis and vectors able
to trans-complement mutations, as have been constructed
for other related Mycoplasma species (Janis et al., 2005),
will be essential. Such methodologies will not only be useful
to drive basic research on molecular pathogenicity, but will
also be valuable for the targeted construction of novel, eﬃ-
cient, and safe vaccines against CBPP in areas where the
disease is endemic. In fact, vaccines currently administered
to cattle are in the form of live bacteria and pose a poten-
tial threat to livestock especially in areas so far free of
CBPP. Their biological safety aspects require particular
attention by implementing safe and non-reversible attenua-
tion sites in new vaccine strains.Acknowledgement
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